Surveillance After Treatment of Localized Breast Cancer: Time for Reappraisal?
- PMID: 30312420
- PMCID: PMC6934435
- DOI: 10.1093/jnci/djy153
Surveillance After Treatment of Localized Breast Cancer: Time for Reappraisal?
Figures
Comment on
-
Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer During Follow-Up and Prognosis.J Natl Cancer Inst. 2019 Apr 1;111(4):380-387. doi: 10.1093/jnci/djy152. J Natl Cancer Inst. 2019. PMID: 30312434 Clinical Trial.
References
-
- Khatcheressian JL, Hurley P, Bantug E, et al. Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;317:961–965. - PubMed
-
- Runowicz CD, Leach CR, Henry NL, et al. American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. J Clin Oncol. 2016;346:611–635. - PubMed
-
- Beaver JA, Kluetz PG, Pazdur R.. Metastasis-free survival—a new end point in prostate cancer trials. N Engl J Med. 2018;37826:2458–2460. - PubMed
-
- Smith MR, Saad F, Chowdhury S, et al. Apalutamide treatment and metastasis-free survival in prostate cancer. N Engl J Med. 2018;37815:1408–1418. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
